⌘K

Login Start Free

Home/Filings/4/0001127602-25-012945

4//SEC Filing

SAGAN PAUL 4

Accession 0001127602-25-012945

CIK 0001682852other

View on SEC.gov Company Profile

Filed

Apr 30, 8:00 PM ET

Accepted

May 1, 4:35 PM ET

Size

5.1 KB

Accession

0001127602-25-012945

Insider Transaction Report

Form 4

Period: 2025-04-30

Moderna, Inc.MRNA

Director

Transactions

Award
Stock Option (Right to Buy)
2025-04-30+25,512→ 25,512 total
Exercise: $28.54Exp: 2035-04-30→ Common Stock (25,512 underlying)

Footnotes (1)

[F1]This option will become fully vested and exercisable on the earlier of April 30, 2026, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

Moderna, Inc.

CIK 0001682852

Entity typeother

Related Parties

1

filerCIK 0001035440

Filing Metadata

Form type: 4
Filed: Apr 30, 8:00 PM ET
Accepted: May 1, 4:35 PM ET
Size: 5.1 KB

View on SEC.gov